ArticleBMC gastroenterology2026
Predisposing factors and histopathological changes in duodenogastric reflux: a retrospective case-control study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuodenogastric reflux (DGR), defined as the retrograde flow of duodenal contents into the stomach, has an incompletely understood pathophysiology. This study aimed to evaluate the relationship between DGR and clinical, endoscopic, histopathological, and laboratory parameters in dyspeptic patients, and to assess its association with Helicobacter pylori (H. pylori) infection, intestinal metaplasia, and potential risk factors.
methodThis retrospective case-control study included 524 patients who underwent upper gastrointestinal endoscopy between January 2017 and December 2022. A total of 287 patients with endoscopic signs of DGR such as bile pooling, mucosal edema, or hyperemia were classified as the DGR group, while 237 patients without these findings served as controls. Clinical, biochemical, endoscopic, and histopathological data were compared, and risk factors were analyzed using multivariate logistic regression.
findingsChemical gastropathy was significantly more frequent in the DGR group (p < 0.001). There were no significant differences regarding intestinal metaplasia or H. pylori positivity (p > 0.05). The DGR group showed higher total bilirubin and lower albumin levels (p < 0.05). Cholecystectomy and cholelithiasis were identified as independent strong risk factors (p < 0.001), while age contributed modestly; gender and H. pylori infection showed no significant association.
conclusionsDGR is a multifactorial condition associated with gastric mucosal injury and systemic biomarker changes. A history of cholecystectomy or gallstones markedly increases DGR risk. Its independent role in intestinal metaplasia remains uncertain, warranting further prospective research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.